GTS Securities’s Applied Therapeutics APLT Stock Holding History

GTS Securities’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-200,009	Closed	-$20K	–	1491
2025 Q4	$20K	Buy	+200,009	New	+$127K	﹤0.01%	1338

GTS Securities's APLT Position: Q1 2026 in Review

GTS Securities sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 200,009 shares — an estimated $20K sold.

GTS Securities first reported a position in APLT in Q4 2025 and held it in 1 quarter. The position peaked at $20K in Q4 2025. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

GTS Securities reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
GTS Securities sold 200,009 Applied Therapeutics shares in Q1 2026, an estimated $20K.
GTS Securities first reported a position in Applied Therapeutics in Q4 2025 and held it in 1 quarter.
GTS Securities's Applied Therapeutics position peaked at $20K in Q4 2025.
0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.